In summary, our present study demonstrates a direct role of nuclear receptor NURR1 in the promotion of both EMT and cancer stemness in prostate cancer through its direct transcriptional control of CTNNB1 and also activation of β-catenin signaling. The gene discussed is CTNNB1; the disease is Familial prostate cancer.